These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23104756)

  • 21. Progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy.
    Yoon CJ
    AIDS Read; 2006 Jun; 16(6):304-6, 309. PubMed ID: 16795920
    [No Abstract]   [Full Text] [Related]  

  • 22. [Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy].
    Waisman JL; Palmero DJ; Alberti FA; Güemes Gurtubay JL; Francos JL; Negroni R
    Medicina (B Aires); 2001; 61(6):810-4. PubMed ID: 11808419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections.
    Meintjes G; Wilkinson RJ
    Clin Infect Dis; 2010 Jun; 50(11):1539-41. PubMed ID: 20415571
    [No Abstract]   [Full Text] [Related]  

  • 24. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death.
    Kaufmann GR; Elzi L; Weber R; Furrer H; Giulieri S; Vernazza P; Bernasconi E; Hirschel B; Battegay M;
    AIDS; 2011 Feb; 25(4):441-51. PubMed ID: 21206265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opportunistic infections in the age of highly active antiretroviral therapy.
    Currier JS
    AIDS Patient Care STDS; 1998 Jul; 12(7):521-5. PubMed ID: 15462002
    [No Abstract]   [Full Text] [Related]  

  • 27. Darunavir: after multiple antiretroviral treatment failure: another option.
    Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opportunistic infections and HIV.
    Ioannidis J; Wilkinson D
    Clin Evid; 2002 Jun; (7):717-37. PubMed ID: 12230699
    [No Abstract]   [Full Text] [Related]  

  • 29. Structured interruptions of therapy: looking for the best protocol.
    Aiuti F; Giovannetti A
    AIDS; 2003 Oct; 17(15):2257-8. PubMed ID: 14523284
    [No Abstract]   [Full Text] [Related]  

  • 30. Explosive nasofacial cryptococosis.
    Persad P; Patel R; Stephens J; Francis-Rogers S; Talat P
    Dermatol Online J; 2010 Mar; 16(3):5. PubMed ID: 20233562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
    De Cock KM; Marston B
    Am J Respir Crit Care Med; 2005 Jul; 172(1):3-4. PubMed ID: 15980107
    [No Abstract]   [Full Text] [Related]  

  • 32. Individualized antiretroviral therapeutic approaches: less can be more.
    Katlama C; Ghosn J; Murphy RL
    AIDS; 2017 May; 31(8):1065-1071. PubMed ID: 28358730
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-retroviral treatment in patients with AIDS and mycobacterial diseases].
    Corti ME; Palmero DJ
    Medicina (B Aires); 2005; 65(4):353-60. PubMed ID: 16193718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?
    Torok ME; Day JN; Hien TT; Farrar JJ
    AIDS; 2005 Mar; 19(5):535-6. PubMed ID: 15764862
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Once-a-day highly active antiretroviral therapy. Present or future?].
    Pulido F; Hernando A
    Med Clin (Barc); 2003 Sep; 121(8):304-9. PubMed ID: 14499087
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of Kaposi sarcoma in human immunodeficiency virus-1-infected Mozambican children with antiretroviral drugs and chemotherapy.
    Vaz P; Macassa E; Jani I; Thome B; Mahagaja E; Madede T; Muando V; Biberfeld G; Anderson S; Blanche S
    Pediatr Infect Dis J; 2011 Oct; 30(10):891-3. PubMed ID: 21730886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
    Moreno A; Pérez-Elías MJ; Casado JL; Fortún J; Bárcena R; Quereda C; Del Campo S; Gutiérrez C; Pastor O; Nuño J; Fernandez A; Moreno S
    Liver Transpl; 2010 Apr; 16(4):530-2. PubMed ID: 20213666
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection.
    McGovern B
    Clin Infect Dis; 2007 Apr; 44(7):1012-3; author reply 1013. PubMed ID: 17342661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.